Shahady, E., & Leahy, J. L. (2019). Sodium–Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes. Clin Diabetes.
Chicago Style aipamenaShahady, Edward, and John L. Leahy. "Sodium–Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes." Clin Diabetes 2019.
MLA aipamenaShahady, Edward, and John L. Leahy. "Sodium–Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes." Clin Diabetes 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.